What is Integra LifeSciences's ENT solutions — total revenues?

Integra LifeSciences (IART) reported ENT solutions — total revenues of $41.2M in Q2 2026.

What does ENT solutions — total revenues mean?

This metric represents the total net sales generated from the Ear, Nose, and Throat (ENT) product portfolio, which includes specialized surgical instruments and regenerative technology solutions. It serves as a key indicator of the company's market penetration and demand within the otolaryngology surgical segment. Tracking this revenue stream helps investors assess the growth trajectory and competitive positioning of the company's specialized medical device offerings.

Integra LifeSciences IART ENT Solutions — Total Revenues

Similar metrics at other companies

PBH

PBHEye & Ear Care — Total revenues

$37.85M-19.0%

BVSSurgical Solutions — Total Net Sales

$48.03M+6.2%

BLCODevices — Total revenues

$524M+11.0%

BLCOSurgical — Total revenues

$256M+18.5%

PHRNetwork solutions — Total revenues

$36.27M+14.6%

GMEDEnabling Technologies — Net Sales

$26.87M+21.1%

Other financials

Income statement

See full

Revenue$418.8M+0.8%

Gross profit$219.7M+5.0%

Operating income$19.3M+104%

Net income$4.5M+101%

EPS (diluted)$0.06+101%

Balance sheet

See full

Cash & equivalents$214.4M-1.6%

Total debt$2.0B+3.2%

Total equity$1.0B+0.5%

Total assets$3.6B-2.8%

Cash flow

See full

Operating cash flow$22.8M+156%

CapEx$12.3M-38.9%

Free cash flow$10.5M+193%

Valuation

See full

Market cap$1.54B+33.5%

Enterprise value$3.29B+14.6%

P/S0.9×+0.2×

Profitability

See full

Gross margin52.5%-0.1pp

Operating margin2.6%+1.3pp

Net margin-0.4%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-0.7%—

Debt / equity1.9×+0.1×

Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Integra LifeSciences’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's ent solutions — total revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's ENT solutions — total revenues?: Integra LifeSciences (IART) reported ENT solutions — total revenues of $41.2M in Q2 2026.
What does ENT solutions — total revenues mean?: This metric represents the total net sales generated from the Ear, Nose, and Throat (ENT) product portfolio, which includes specialized surgical instruments and regenerative technology solutions. It serves as a key indicator of the company's market penetration and demand within the otolaryngology surgical segment. Tracking this revenue stream helps investors assess the growth trajectory and competitive positioning of the company's specialized medical device offerings.